More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$59637407
EPS
-2.45
P/E ratio
--
Price to sales
0.65
Dividend yield
--
Beta
1.923512
Previous close
$3.39
Today's open
$3.35
Day's range
$3.12 - $3.36
52 week range
$2.84 - $6.49
show more
CEO
Leslie Trigg
Employees
310
Headquarters
San Jose, CA
Exchange
Nasdaq Global Select
Shares outstanding
18872597
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
All You Need to Know About Outset Medical (OM) Rating Upgrade to Buy
Outset Medical (OM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research • Nov 12, 2026

Outset Medical Q3 Earnings Call Highlights
Outset Medical NASDAQ: OM reported third-quarter 2026 revenue of $33.6 million, up 14% from a year earlier, as sales of its Tablo dialysis consoles increased and recurring revenue grew. The company reiterated its full-year revenue guidance of $125 million to $130 million.
MarketBeat • Nov 5, 2026

Outset Medical, Inc. (OM) Q3 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 5, 2026

Outset Medical Reports Third Quarter 2026 Results
SAN JOSE, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the third quarter ended September 30, 2026.
GlobeNewsWire • Nov 4, 2026

Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to a loss of $0.69 per share a year ago.
Zacks Investment Research • Nov 5, 2026

Outset Medical to Participate in the 2026 Stifel Healthcare Conference
SAN JOSE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will participate in a fireside chat at the 2026 Stifel Healthcare conference on Tuesday, November 10, 2026, at 1:20 p.m.
GlobeNewsWire • Oct 27, 2026

Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
SAN JOSE, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter 2026 after the close of trading on Wednesday, November 4, 2026.
GlobeNewsWire • Oct 21, 2026

Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
Outset Medical (OM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Zacks Investment Research • Aug 18, 2026

Outset Medical Q2 Earnings Call Highlights
Outset Medical NASDAQ: OM reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare.
MarketBeat • Aug 7, 2026

Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Seeking Alpha • Aug 7, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Outset Medical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.